Preferred Drug List Changes for Hepatitis C
Date: 08/18/16
The California Health & Wellness Pharmacy and Therapeutics (P&T) Committee reviews the Preferred Drug List (PDL) at least quarterly to determine placement of medications on the drug list and any limitations to coverage. The list below details PDL changes resulting from a P&T Committee vote in August 2016.
| Drug Name | PDL Status | Comments |
| Epclusa® 400-100mg tab (Sofosbuvir-Velpatasvir) | Add to PDL 8/2016 | Preferred. Prior Authorization Required |
| Zepatier® 50-100mg tab (Elbasvir-Grazoprevir) | Add to PDL 8/2016 | Preferred. Prior Authorization Required |
| Harvoni® 90-400mg tab (Ledipasvir-Sofosbuvir) | Remove from PDL 10/1/2016 | Non-preferred. PA Required for Medical Necessity |
| Sovaldi® 400mg tab (Sofosbuvir) | Remove from PDL 10/1/2016 | Non-preferred. PA Required for Medical Necessity |